Gynecology and Obstetrics Research · Vol. 9, No. 1 · 2023 · pp. 19–20 · e-ISSN 2377-1542

Erratum: Induced Pluripotent Stem Cells—Derived Stem Cells: A Promising Tool for Disease Modeling

Parveen Parasar

Department of Neurology, Henry Ford Hospital, Detroit 48202, MI, USAUnited States

DOI: https://doi.org/10.17140/goroj-9-160 · Published 2023-05-10 · Licence: https://creativecommons.org/licenses/by/4.0 · © 2023 The Author(s)

Also available as PDF (figures and tables appear in the PDF).

Abstract

Erratum Unfortunately, there was an error in the original version of this article. The authors wish to delete the following sentence in the conclusion section: For example, in neurological rare metabolic disease, X ALD, there is no genotype phenotype correction and due to inaccessibility of tissue samples, research presents caveats in discovery of biomarkers. This statement has been now corrected. The publisher and the author would like to apologise for any inconvenience caused to the readers. The change does not affect the scientific results. The corrected manuscript is updated and the original will remain online on the article webpage.

Conclusion

Due to lack of direct translatable animal models, it is needed that an in vitro cellular model derived from patient-derived iPSCs be created which provides a platform and cellular system to investigate pathogenetic mechanisms of diseases. Currently, various diseases due to nature of their rare occurrence and/or fatal outcomes, result in lack of patient tissue samples and specimen and subjects to characterize diseases. The development of patient-derived stem cell model enables us to discover novel biomarkers of diseases and design and screen therapies.

Correction Statement

This correction is to keep the overall gist of the manuscript in the context of reproductive diseases and pregnancy disorders. The statement made previously regarding X-ALD is not related to pregnancy and therefore, being an expert in the field of reproductive immunology, I would like to correct this statement. When I gain more experience in the field of neurological diseases, I may write such statement in a neurology-specific journal. Thank you for understanding.

References

  1. MarchettoMCBrennandKJBoyerLFGageFH. Induced pluripotent stem cells (iPSCs) and neurological disease modeling: Progress and promises. Hum Mol Genet. 2011; 20(R2): R109-R115. doi: 10.1093/hmg/ddr33610.1093/hmg/ddr336 https://doi.org/10.1093/hmg/ddr336
  2. EbertADLiangPWuJC. Induced pluripotent stem cells as a disease modeling and drug screening platform. J Cardiovasc Pharmacol. 2012; 60(4): 408-416. doi: 10.1097/FJC.0b013e318247f64210.1097/fjc.0b013e318247f642 https://doi.org/10.1097/fjc.0b013e318247f642
  3. TakahashiKYamanakaS. Induction of pluripotent stem cells
  4. LiangKXKristiansenCKMostafaviS. Disease-specific phenotypes in iPSC-derived neural stem cells with POLG mutations. EMBO Mol Med. 2020; 12(10): e12146. doi: 10.15252/ emmm.202012146
  5. JosephRBalesKSrivastavaKSrivastavaO. Lens epithelial cells-induced pluripotent stem cells as a model to study epithelial-mesenchymal transition during posterior capsular opacification. Biochem Biophys Rep. 2019; 20: 100696. doi: 10.1016/j. bbrep.2019.10069610.1016/j.bbrep.2019.100696 https://doi.org/10.1016/j.bbrep.2019.100696
  6. LipskindSLindseyJSGerami-NainiB. An embryonic and induced pluripotent stem cell model for ovarian granulosa cell development and steroidogenesis. Reprod Sci. 2018; 25(5): 712-726. doi: 10.1177/193371911772581410.1177/1933719117725814 https://doi.org/10.1177/1933719117725814
  7. CozzolinoMMarinDSistiG. New Frontiers in IVF: mtDNA and autologous germline mitochondrial energy transfer. Reprod Biol Endocrinol. 2019; 17(1): 55. doi: 10.1186/s12958-019-0501-z10.1186/s12958-019-0501-z https://doi.org/10.1186/s12958-019-0501-z
  8. GulimiheranmuMWangXZhouJ. Advances in female germ cell induction from pluripotent stem cells. Stem Cells Int. 2021; 2021: 8849230. doi: 10.1155/2021/884923010.1155/2021/8849230 https://doi.org/10.1155/2021/8849230
  9. LarondaMMBurdetteJEKimJWoodruffTK. Recreating the female reproductive tract in vitro using iPSC technology in a linked microfluidics environment. Stem Cell Res Ther. 2013; 4 Suppl 1: S13. doi: 10.1186/scrt37410.1186/scrt374 https://doi.org/10.1186/scrt374
  10. McTagueARossignoliGFerriniABarralSKurianMA. Genome editing in iPSC-based neural systems: From disease models to future therapeutic strategies. Front Genome Ed. 2021; 3: 630600. doi: 10.3389/fgeed.2021.63060010.3389/fgeed.2021.630600 https://doi.org/10.3389/fgeed.2021.630600